Home › Pancreatic Diseases › NCT06340620
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Recruiting
Randomized Trial of Endoscopic Ultrasound Examination Using EndoSound Vision System vs. Standard Echoendoscope
Who can join
Ages 18 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age ≥ 18 years * Any patient undergoing EUS examination for evaluation of the pancreas, bile duct, mediastinal or intraabdominal lymph nodes, or luminal lesions in the esophagus, stomach, duodenum or colon. Exclusion Criteria: * Age \< 18 years. * Unable to obtain consent for the procedure from either the patient or LAR. * Intrauterine pregnancy.
About the study
This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
What is being tested
- Endoscopic ultrasound examination (device)
Sponsor: Orlando Health, Inc. · Participants: 140 · Started: Mar 25, 2024
Contact the study team
- Ji Young Bang, MD MPH · Phone: 321-841-2431
- Barbara Broome · Phone: 321-841-4356
Official record on ClinicalTrials.gov — NCT06340620
Locations in the U.S.
| Florida | Orlando Health, Orlando |
Conditions
- Pancreatic Diseases
- Pancreatic Cancer
- Pancreatic Cyst
- Digestive System Cancer
- Bile Duct Cancer
- Gastrointestinal Cancers
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.